Reference pricing, competition, and pharmaceutical expenditures: Theory and evidence from a natural experiment
-
Stempeutics Gets Stem Cell Patent In China (Chinese Application Number: CN201080053627) For Its Novel Stem Cell Drug ‘Stempeucel’ – Courtesy(Biospace)
Pharma Live, , Intellectual Property Rights, 0
Stempeutics Research, a group company of Manipal Education and Medical Group and a Joint Venture with Cipla Group, announced...
-
Court Cites Objects Of Invention In Claim Construction – Courtesy (Pharma Patents)
Pharma Live, , Intellectual Property Rights, 0
POSTED BY COURTENAY C. BRINCKERHOFF ON 24 FEBRUARY 2015POSTED IN CLAIM CONSTRUCTION;FEDERAL CIRCUIT DECISIONSPacing Technologies, LLC v. Garmin International, Inc. is one of...
-
Patent Safe Harbor Applies To Supplemental New Drug Applications
Pharma Live, , Intellectual Property Rights, 0
POSTED BY JACOB D. MOORE AND COURTENAY C. BRINCKERHOFF ON 21 MAY 2015POSTED IN FEDERAL CIRCUIT DECISIONS;INFRINGEMENTOn May 13, 2015, the Federal Circuit confirmed...
-
FDA Releases Draft Guidance on Biosimilars
Pharma Live, , Intellectual Property Rights, 0
POSTED BY COURTENAY C. BRINCKERHOFF ON 9 FEBRUARY 2012POSTED IN BIOSIMILARSOn February 9, 2012, the FDA issued long-awaited (draft) guidance documents on...
-
Prepare for the Japanese Patent Opposition System Coming Soon – Courtesy (Global IP Matters)
Pharma Live, , Intellectual Property Rights, 0
The Japanese Patent Act was revised on May 14, 2014 to provide for post-grant oppositions within one year of the rule...
-
Orphan drug market to reach $176bn by 2020 – Courtesy ( PMLiVe)
Pharma Live, , Intellectual Property Rights, 0
pharmacistThe global orphan drug market is expected to account for 19% of all branded prescription drug sales by 2020,...
-
Louisiana Challenge’s AstraZeneca on Antitrust Claims for Asserting Invalid Drug Patents – Courtesy(PATENTLYO)
Pharma Live, , Intellectual Property Rights, 0
In March 2015, the state of Louisiana filed suit against AstraZeneca alleging antitrust violations based upon the company’s actions of...
-
Drug Patents: A New Hedge Fund Target – Courtesy ( Seeking Alpha.com)
Pharma Live, , Intellectual Property Rights, 0
Summary Hedge funds managers are attacking what they see as “weak patents” held by pharmaceutical companies while they are...